Bit Capital Gmb H Milestone Pharmaceuticals Inc. Transaction History

Bit Capital Gmb H

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Feb 12, 2025	SELL	$1.4 - $2.2 $28,000 - $44,000	-20,000 Closed	0 $0
Q4 2023 Feb 12, 2025	SELL	$1.67 - $3.39 $312,750 - $634,865	-187,276 Reduced 90.35%	20,000 $33.4 Million
Q2 2023 Feb 12, 2025	BUY	$2.85 - $4.4 $25,650 - $39,600	9,000 Added 4.54%	207,276 $591 Million
Q1 2023 Feb 12, 2025	BUY	$3.14 - $4.2 $429,476 - $574,459	136,776 Added 222.4%	198,276 $781 Million
Q4 2022 Feb 12, 2025	BUY	$3.53 - $9.5 $217,095 - $584,250	61,500 New	61,500 $244 Million

27.9M

200

Ticker MIST
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,010,900
Market Cap $68.7M
Description
Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...

Get notified when there are updates to the investment portfolio of Bit Capital Gmb H, based on Form 13F filings with the SEC.

Stay updated on Bit Capital Gmb H with notifications on news.